ArticlePhysics and imaging in radiation oncology2026
Geometry-based framework for beam angle selection in proton therapy for lung cancer.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Proton therapy is a promising modality for treating locally advanced non-small cell lung cancer (LA-NSCLC). However, respiratory-induced intra-fractional motion can compromise tumour coverage. This work aimed to develop a method to identify proton beam angles that balance tumour coverage and organ-at-risk (OAR) sparing. Materials and methods: An open-source dataset of eleven LA-NSCLC patients with four-dimensional CT (4DCT) scans was analysed. For each gantry-couch angle, the water equivalent path length variation (ΔWEPL) and percentage irradiated volume (PIV) were calculated using in-house code to serve as metrics for tumour motion sensitivity and geometric OAR exposure. A unified risk map was constructed based on ΔWEPL and PIV, with patient-specific weighting factors and constraints to enable individualised beam selection. Subsequent single-beam treatment plans were generated on the average intensity projection CT, with the dose distribution recalculated on all breathing phases to derive ΔD Results: ΔWEPL correlated with target dose degradation (median r = 0.90 for ΔD Conclusions: Patient-specific proton beam angle selection by combining ΔWEPL and PIV into a unified risk map offers a clinically relevant strategy to improve robustness and OAR sparing for LA-NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.